TUMOUR BIOMARKER AND PLASMA TIME COURSE DATA FROM ABIGAIL, A PHASE II STUDY OF 1ST-LINE BEVACIZUMAB plus CHEMOTHERAPY IN ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NS-NSCLC)
Autor: | Reck, M., Gorbunova, V. A., Juhasz, E., Szima, B., Orlov, S., Yu, C., Pallaud, C., Scherer, S. J., Archer, V., Tony Mok |
---|---|
Zdroj: | ResearcherID Publons |
Databáze: | OpenAIRE |
Externí odkaz: |